Arbutus Biopharma
ABUS
ABUS
39 hedge funds and large institutions have $97.6M invested in Arbutus Biopharma in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
61% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 18
Holders
39
Holding in Top 10
–
Calls
$1.47M
Puts
$1.05M
Top Buyers
| 1 | +$3.65M | |
| 2 | +$1.78M | |
| 3 | +$1.75M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$1.58M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$1.42M |
Top Sellers
| 1 | -$5.01M | |
| 2 | -$3.18M | |
| 3 | -$2.92M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.14M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.06M |